Validation of a nuclear grading system for resected stage I-IIIA, high-risk, node-negative invasive breast carcinoma in the N.SAS-BC 01 trial (Apr, 10.1007/s12282-022-01350-4, 2022)

被引：0

作者：

Tsuda, Hitoshi ^{[1
]}

Kurosumi, Masafumi ^{[2
]}

Akiyama, Futoshi ^{[3
]}

Ohno, Shinji ^{[4
]}

Saji, Shigehira ^{[5
]}

Masuda, Norikazu ^{[6
]}

Shimomura, Akihiko ^{[7
]}

Sato, Nobuaki ^{[8
]}

Takao, Shintaro ^{[9
]}

Ohsumi, Shozo ^{[10
]}

Tokuda, Yutaka ^{[11
]}

Inaji, Hideo ^{[12
]}

Watanabe, Toru ^{[13
]}

机构：

[1] Natl Def Med Coll, Saitama, Japan

[2] Kameda Med Ctr, Chiba, Japan

[3] Japanese Fdn Canc Res, Inst Canc, Tokyo, Japan

[4] Canc Inst Hosp Japanese Fdn Canc Res, Tokyo, Japan

[5] Fukushima Med Univ, Fukushima, Japan

[6] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan

[7] Natl Canc Ctr, Tokyo, Japan

[8] Niigata Canc Ctr Hosp, Niigata, Japan

[9] Hyogo Canc Ctr, Akashi, Hyogo, Japan

[10] NHO Shikoku Canc Ctr, Shikoku, Ehime, Japan

[11] Tokai Univ, Sch Med, Tokyo, Japan

[12] Kaizuka City Hosp, Osaka, Japan

[13] Hamamatsu Oncol Ctr, Shizuoka, Japan

来源：

BREAST CANCER | 2022年 / 29卷 / 04期

关键词：

D O I：

10.1007/s12282-022-01367-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：730 / 730

页数：1

共 4 条

[1] Validation of a nuclear grading system for resected stage I-IIIA, high-risk, node-negative invasive breast carcinoma in the N•SAS-BC 01 trial
Tsuda, Hitoshi
Kurosumi, Masafumi
Akiyama, Futoshi
Ohno, Shinji
Saji, Shigehira
Masuda, Norikazu
Shimomura, Akihiko
Sato, Nobuaki
Takao, Shintaro
Ohsumi, Shozo
Tokuda, Yutaka
Inaji, Hideo
Watanabe, Toru
BREAST CANCER, 2022, 29 (04) : 720 - 729
[2] Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial
Hitoshi Tsuda
Masafumi Kurosumi
Futoshi Akiyama
Shinji Ohno
Shigehira Saji
Norikazu Masuda
Akihiko Shimomura
Nobuaki Sato
Shintaro Takao
Shozo Ohsumi
Yutaka Tokuda
Hideo Inaji
Toru Watanabe
Breast Cancer, 2022, 29 : 720 - 729
[3] Correction to: Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial
Hitoshi Tsuda
Masafumi Kurosumi
Futoshi Akiyama
Shinji Ohno
Shigehira Saji
Norikazu Masuda
Akihiko Shimomura
Nobuaki Sato
Shintaro Takao
Shozo Ohsumi
Yutaka Tokuda
Hideo Inaji
Toru Watanabe
Breast Cancer, 2022, 29 : 730 - 730
[4] Histopathological nuclear grading system for high-risk node-negative invasive breast cancer in the NSAS-BC-01 trial
Tsuda, Hitoshi
Kurosumi, Masafumi
Akiyama, Futoshi
Ohno, Shinji
Masuda, Norikazu
Saji, Shigehira
Shimomura, Akihiko
Sato, Nobuaki
Takao, Shintaro
Ohsumi, Shozo
Tokuda, Yutaka
Inaji, Hideo
Watanabe, Toru
Ohashi, Yasuo
CANCER SCIENCE, 2021, 112 : 824 - 824

← 1 →